As of 2025-07-01, the EV/EBITDA ratio of Aspira Women's Health Inc (AWH) is -0.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AWH's latest enterprise value is 2.14 mil USD. AWH's TTM EBITDA according to its financial statements is -12.97 mil USD. Dividing these 2 quantities gives us the above AWH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.0x - 23.4x | 19.6x |
| Forward P/E multiples | 23.2x - 23.7x | 23.5x |
| Fair Price | (13.81) - (13.92) | (12.83) |
| Upside | -16943.1% - -17073.5% | -15751.3% |
| Date | EV/EBITDA |
| 2025-05-09 | -0.14 |
| 2025-05-08 | -0.18 |
| 2025-05-07 | -0.14 |
| 2025-05-06 | -0.13 |
| 2025-05-05 | -0.14 |
| 2025-05-02 | -0.14 |
| 2025-05-01 | -0.14 |
| 2025-04-30 | -0.13 |
| 2025-04-29 | -0.13 |
| 2025-04-28 | -0.17 |
| 2025-04-25 | -0.13 |
| 2025-04-24 | -0.09 |
| 2025-04-23 | -0.07 |
| 2025-04-22 | -0.08 |
| 2025-04-21 | -0.06 |
| 2025-04-17 | -0.07 |
| 2025-04-16 | -0.17 |
| 2025-04-15 | -0.18 |
| 2025-04-14 | -0.19 |
| 2025-04-11 | -0.19 |
| 2025-04-10 | -0.19 |
| 2025-04-09 | -0.19 |
| 2025-04-08 | -0.18 |
| 2025-04-07 | -0.18 |
| 2025-04-04 | -0.19 |
| 2025-04-03 | -0.20 |
| 2025-04-02 | -0.21 |
| 2025-04-01 | -0.19 |
| 2025-03-31 | -0.19 |